Title | Preadmission predictors of severe COVID-19 in patients with diabetes mellitus. |
Publication Type | Journal Article |
Year of Publication | 2021 |
Authors | Shukla AP, Tchang BG, Lam T, Steller I, Touhamy S, Askin G, Curanaj FAMendelso, Seley JJ, Lorber D, Safford MM, Aronne LJ, Alonso LC |
Journal | J Diabetes Complications |
Volume | 35 |
Issue | 8 |
Pagination | 107967 |
Date Published | 2021 08 |
ISSN | 1873-460X |
Keywords | Adult, Aged, Aged, 80 and over, Body Mass Index, Comorbidity, Continental Population Groups, COVID-19, Diabetes Mellitus, Type 2, Female, Humans, Intensive Care Units, Male, Middle Aged, New York, Obesity, Patient Admission, Prognosis, Retrospective Studies, Risk Factors, SARS-CoV-2, Severity of Illness Index |
Abstract | OBJECTIVE: To explore predictors of severe COVID-19 disease in patients with diabetes hospitalized for COVID-19. METHODS: This is a retrospective observational study of adults with diabetes admitted for COVID-19. Bivariate tests and multivariable Cox regression were used to identify risk factors for severe COVID-19, defined as a composite endpoint of intensive care unit admission/intubation or in-hospital death. RESULTS: In 1134 patients with diabetes admitted for COVID-19, more severe disease was associated with older age (HR 1.02, p<0.001), male sex (HR 1.28, p=0.017), Asian race (HR 1.34, p=0.029 [reference: white]), and greater obesity (moderate obesity HR 1.59, p=0.015; severe obesity HR 2.07, p=0.002 [reference: normal body mass index]). Outpatient diabetes medications were not associated with outcomes. CONCLUSIONS: Age, male sex, Asian race, and obesity were associated with increased risk of severe COVID-19 disease in adults with type 2 diabetes hospitalized for COVID-19. SUMMARY: In patients with type 2 diabetes hospitalized for COVID-19 disease, we observed that age, male sex, Asian race, and obesity predicted severe COVID-19 outcomes of intensive care unit admission, intubation, or in-hospital death. The risk conferred by obesity increased with worsening obesity. Outpatient diabetes medications were not observed to be significant predictors of study outcomes. |
DOI | 10.1016/j.jdiacomp.2021.107967 |
Alternate Journal | J Diabetes Complications |
PubMed ID | 34099384 |
PubMed Central ID | PMC8162023 |
Grant List | UL1 TR002384 / TR / NCATS NIH HHS / United States |